Maria A. Lopez-Olivo, M.D., M.Sc., Ph.D.
Department of Health Services Research, Division of Cancer Prevention and Population Sciences
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Health Services Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Department of Cochrane US Affiliate The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
I am a health services researcher specializing in evidence synthesis and knowledge translation, with a focus on autoimmune diseases, rheumatic conditions, and their associations with cancer. My work applies systematic reviews, meta-analyses, and evidence appraisal to support clinical guideline development and healthcare decision-making. As the Director of Cochrane Activities at MD Anderson, I oversee systematic review initiatives and mentor researchers in evidence synthesis methodologies. My knowledge translation efforts have focused on developing and evaluating educational tools for patients and summarizing evidence for healthcare providers through Cochrane summaries. I have also conducted environmental scans of online health resources and assessed physician perspectives on clinical practices to enhance the accessibility and usability of synthesized evidence in clinical settings.
Education & Training
Degree-Granting Education
| 2005 | Universidad de Guadalajara, Guadalajara, US, Ph.D. in Clinical Pharmacology |
| 2003 | Universidad de Guadalajara, Guadalajara, MX, M.S. in Pharmacology |
| 2001 | Universidad de Guadalajara, Guadalajara, MX, MD |
Postgraduate Training
| 2022-2022 | Early Investigator Advancement Program, National Cancer Institute Equity and Inclusion Program |
| 2021-2021 | Mentorship and Leadership on Cancer-related Health Disparities Program, National Cancer Institute Awardee Skills Development Consortium, Houston, Texas |
| 2021-2021 | Academic Career Skills: Leadership, Collaboration, and Resilience, National Cancer Institute Awardee Skills Development Consortium, Houston, Texas |
| 2020-2020 | Training Institute for Dissemination and Implementation Research in Cancer, The National Cancer Institute Division of Cancer Control and Population Sciences, Houston, Texas |
| 2016-2018 | Certificate, Foundational Aspects of Medical Decision Making, Core Course Curriculum, Society for Medical Decision Making |
| 2008-2010 | Certificate, Clinical Research, University of Texas Medical School at Houston, Houston, Texas |
| 2006-2010 | Postdoctoral Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2005-2006 | Research Fellowship, Health Services Research, Baylor College of Medicine, Houston, Texas |
| 2002-2005 | Residency, Rheumatology-Research, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco |
| 2001-2002 | Certificate, Toxicology, Colegio de Toxicologia del Estado de Jalisco, Guadalajara, Jalisco |
| 2000-2001 | Certificate, Bioethics, Centro Universitario en Ciencias de la Salud, Guadalajara, Jalisco |
| 1999-2000 | Clinical Internship, Secretaria de Salud, Guadalajara, Jalisco |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2021
Assistant Professor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2019
Instructor, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2013
Other Professional Positions
Chair, Development of the ACR/EULAR classification criteria for Immune Related Inflammatory Arthritis, OMERACT, Houston, Texas, 2022 - Present
Director, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Institutional Committee Activities
Member, Department Wellness Leads, 2024 - Present
Member, Executive Committee of the Faculty Senate (ECFS), 2023 - 2025
Member, Mid-Career Faculty Committee, 2023 - Present
Senator, MD Anderson Cancer Center Faculty Senate, 2022 - Present
Member, MD Anderson Cancer Center Faculty Senate Risk Detection and Outcomes Program MD Anderson’s Cancer Center Support Grant (CCSG), 2022 - Present
Member, Division of Cancer Prevention and Population Sciences Diversity and Inclusion Initiative - Advisory Committee, 2020 - 2023
Member, Institutional Review Board 2 Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2013
Member, Psychosocial, Behavioral, and Health Services Research Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2015
Member, Division of Internal Medicine Research Committee, The University of Texas MD Anderson Cancer Center, 2010 - 2012
Member, Bioethics and Research Committee, Instituto Mexicano del Seguro Social Hospital General Regional 110, 2002 - 2004
Honors & Awards
| 2026 - 2027 | National Researcher Level 1, CONACyT – Mexican Council for Science and Technology |
| 2024 | Poster Finalist 2024 Professional Development Workshop, National Cancer Institute |
| 2022 | Nominated for the 2022 Leading Mentor in Cancer Prevention Award, Cancer Prevention Research Training Program |
| 2021 | Division of Cancer Prevention Distinguished Paper Award, The University of Texas MD Anderson Cancer Center |
| 2016 | Finalists for the Trainee Excellence in Research Poster Award and Finalists for the Staff Excellence in Research Poster Award, 2016 Cancer Survivorship Research Symposium |
| 2016 | Best Research Abstract at the Perioperative Cancer Anaesthesia Conference, Royal Marsden NHS Foundation Trust |
| 2015 | Poster Finalist, Division of Internal Medicine Research Retreat |
| 2014 - 2022 | National Researcher Level 2, CONACyT - Mexican Council for Science and Technology |
| 2013 | Best Research Project, Kelsey Seybold Research Foundation |
| 2012 | Division of Internal Medicine's Distinguished Paper Award of the Quarter, The University of Texas MD Anderson Cancer Center |
| 2011 - 2013 | National Researcher Level 1, CONACyT – Mexican Council for Science and Technology |
| 2011 | Department of General Internal Medicine Educator of the Year, University of Texas MD Anderson Cancer Center |
| 2008 | Bursary Award, SPondyloArthritis Research & Treatment Network |
| 2008 | Bursary Award, American College of Rheumatology |
| 2007 | Best Research Project in Clinical Aspects and Treatment, European League Against Rheumatism |
| 2007 | Best Research Project in Rheumatology, Mexican College of Rheumatology |
Grant & Contract Support
| Date: | 2024 - 2025 |
| Title: | Optimizing the Work of Emerging Champions for Cancer Control Interventions in the Community and Clinic |
| Funding Source: | NIH/NCI |
| Role: | Consult |
| Date: | 2023 - 2028 |
| Title: | Cancer Prevention Education: Student Research Experiences |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | FP00016741 |
| Date: | 2023 - 2028 |
| Title: | Methods Training for Comparative Effectiveness Research in Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R25CA257883 |
| Date: | 2023 - 2028 |
| Title: | Patterns of E-cigarette use and attitudes among cancer survivors |
| Funding Source: | Survivorship IRG |
| Role: | PI |
| ID: | FP00128765 |
| Date: | 2021 - 2025 |
| Title: | Effects of Biologic and Targeted Therapies for Rheumatoid Arthritis on Cancer Outcomes |
| Funding Source: | NIH/NIAMS |
| Role: | Co-I |
| ID: | 5R01AR078484 |
| Date: | 2020 - 2026 |
| Title: | Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | K08CA237619 |
Selected Publications
Peer-Reviewed Articles
- Laserna A, Cuenca JA, Martin P, Fowler C, Barahona-Correa J, Manjappachar N, Fowler C, Lopez-Olivo MA, Borges M, Sprung CL, Nates JL. Mortality time frame variability in septic shock clinical trials: A systematic review. Medicina intensiva, 2025. e-Pub 2025.
- Tan, NQ, Nargund, R, Douglas, E, Lopez-Olivo, MA, Resong, PJ, Ishizawa, S, Nofal, S, Krause, KJ, Volk, R, Toumazis, I. Acceptability and perceptions of personalised risk-based cancer screening among health-care professionals and the general public. The Lancet Public Health 10(2):e85-e96, 2025. e-Pub 2025. PMID: 39909697.
- Lopez-Olivo MA, Kachira JJ, Madramootoo S, Michaud K, Schumacher R, Cinciripini P, Suarez-Almazor ME. Physician views and attitudes regarding tobacco-cessation strategies for patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 77(6):767-776, 2025. e-Pub 2025. PMID: 39828986.
- Bowman S, Agarwal SK, Ferguson KC, Maliekel MJ, Lopez-Olivo MA, Suarez-Almazor ME, Danila MI, Yazdany J, Bruera S. Telemedicine for under-resourced patients with systemic lupus erythematosus: a qualitative study exploring the views and experiences of patients and their healthcare team. Front Health Serv 5:1503881, 2025. e-Pub 2025. PMID: 40476195.
- Bruera S, Bowman S, Huang Y, Suarez-Almazor ME, Lo GH, Lopez-Olivo M, Chiao E, Kramer JR, Pereira FA, Agarwal SK. Factors associated with adherence of cervical cancer screening in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 76(9):1224-1231, 2024. e-Pub 2024. PMID: 38682616.
- Lopez-Olivo MA, Kachira JJ, Abdel-Wahab N, Pundole X, Aldrich JD, Carey P, Khan M, Geng Y, Pratt G, Suarez-Almazor ME. A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease. Eur J Cancer 207:114148, 2024. e-Pub 2024. PMID: 38834015.
- Lopez-Olivo MA, James J, James J, Krause KJ, Roth M, Palos GR, Ma H, Rodriguez A, Gilmore K, Cinciripini P, Suarez-Almazor ME. A systematic review and meta-analysis of e-cigarette use among cancer survivors. J Cancer Surviv 18(3):1059-1074, 2024. e-Pub 2023. PMID: 36952212.
- Weinbrecht-Mischkewitz, M, Kamal, M, Asim, F, Guillemin, F, Goel, N, Voshaar, M, Boonen, A, Berthelsen, DB, Toupin-April, K, Lopez-Olivo, MA, Sloan, VS, Boers, M, Jones, CA, van der Horst-Bruinsma, IE, Cashin, AG, Sharma, S, Leong, AL, Alten, R, Shea, B, March, LM, Tugwell, P, Christensen, R, Nielsen, SM. Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies. Seminars in Arthritis and Rheumatism 65, 2024. e-Pub 2024. PMID: 38290371.
- Benavent, D, Carmona, L, Lopez-Olivo, MA, Hill, CL, Westrich-Robertson, T, Goel, N, Strand, V, Shea, B, Grosskleg, S, Leong, AL, Hofstetter, C, Bingham, C, Meyer, D, Constien, D, Berthelsen, DB, Schultz, G, de Groot, I, Weiner, J, Mather, K, De Wit, M, Böhm, P, Cembalo, SM, Tugwell, P, Bruera, S, Suarez-Almazor, M. Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis. Seminars in Arthritis and Rheumatism 64, 2024. e-Pub 2024. PMID: 38118370.
- Lopez-Olivo, MA, Suarez-Almazor, M, Duhon, GF, Cherry, M, Lu, H, Calabrese, C, Altan, M, Tawbi, H, Meara, A, Bingham, CO, Diab, A, Leal, VB, Volk, R. Development of an Educational Website for Patients With Cancer and Preexisting Autoimmune Diseases Considering Immune Checkpoint Blockers. JMIR Cancer 10, 2024. e-Pub 2024.
- Lopez-Olivo MA, Lin H, Parker S, Barbo Barthel A, Suarez-Almazor ME. Impact of decision-making role preferences on the efficacy of educational tools for patients with common rheumatologic conditions. Rheum Int. e-Pub 2024.
- Manzano JG, Sharma S, Lopez-Olivo MA, Suarez-Almazor ME. Association of diabetes treatment with breast cancer outcomes: a systematic review and meta-analysis. Supportive Care in Cancer. e-Pub 2024.
- Ruiz JI, Burugu V, Lopez-Olivo MA, Geng Y, Suarez-Almazor ME. Clinical practice guidelines recommendations about cancer screening in patients with autoimmune diseases: a systematic review. e-Pub 2024.
- Lopez-Olivo MA, Madramootoo S, Kachira JJ, Michaud K, Schumacher R, Cinciripini P, Suarez-Almazor ME. Preferences regarding tobacco cessation strategies, barriers to success in cessation , and perceived needs of patients with rheumatoid arthritis. Seminars in arthritis and rheumatism. e-Pub 2024.
- Corps KN, Terry O, Geng Y, Meara AS, Liew D, Kostine M, Lopez-Olivo MA. The impact of immune-related adverse events in cancer patients: A systematic review with meta-synthesis. Critical reviews in oncology/hematology. e-Pub 2024.
- Ruiz JI, Madramootoo ST, Lopez-Olivo MA, Singh N, Suarez-Almazor ME. Beliefs, Attitudes, and Preferences of Patients with Rheumatoid Arthritis (RA) and Concomitant Cancer with Respect to RA Therapy. Arthritis Rheumatol 75(suppl 9), 2023. e-Pub 2023.
- Lopez-Olivo MA, Suarez-Almazor ME, Duhon GF, Erck M, Lu H, Calabrese C, Altan M, Tawbi H, Meara A, Bingham CO, Diab A, Leal VB, Volk RJ. Development and user testing of a website for cancer patients with pre-existing autoimmune disease who are considering immune checkpoint inhibitor therapy. JIMR Cancer 11(Suppl 1), 2023. e-Pub 2023.
- Talwar A, Lopez-Olivo MA, Huang Y, Ying L, Aparasu RR. Advanced machine learning algorithms perform better than logistic regression in predicting hospital readmissions: A meta-analysis. Explor Res Clin Soc Pharm 11:100317, 2023. e-Pub 2023. PMID: 37662697.
- Lopez-Olivo MA, Kachira JJ, Buni M, Kim ST, Lu H, Tayar JH, Duhon GF, Ruiz JI, Bingham CO 3rd, Calabrese C, Volk RJ, Suarez-Almazor ME. Learning needs of patients with cancer and a pre-existing autoimmune disease who are candidates to receive immune checkpoint inhibitors. Cancers (Basel) 15(15), 2023. e-Pub 2023. PMID: 37568819.
- Lopez-Olivo MA, Michaud K, Schumacher R, Minnix J, Cinciripini P, Suarez-Almazor ME. Smoking cessation patterns, usefulness of quitting methods, and tobacco cessation motivators and barriers to quit in patients with rheumatoid arthritis. Clin Rheumatol 42(8):2053-2068, 2023. e-Pub 2023. PMID: 37093403.
- Bruera S, Sreedhar A, Agarwal SK, Muthukumar V, Geng Y, Lopez-Olivo MA. Immunosuppression for the treatment of pulmonary hypertension in patients with systemic lupus erythematosus: A systematic review. Int J Rheum Dis 26(6):1022-1028, 2023. e-Pub 2023. PMID: 37140198.
- Lowenstein LM, Shih YT, Minnix J, Lopez-Olivo MAA, Maki KG, Kypriotakis G, Leal VB, Shete SS, Fox J, Nishi SP, Cinciripini PM, Volk RJ. A protocol for a cluster randomized trial of care delivery models to improve the quality of smoking cessation and shared decision making for lung cancer screening. Contemp Clin Trials 128:107141, 2023. e-Pub 2023. PMID: 36878389.
- Ruiz JI, Lopez-Olivo MA, Geng Y, Suarez-Almazor ME. COVID-19 outcomes in patients with cancer receiving immune checkpoint inhibitors: a systematic review. J Immunother Precis Oncol 6(2):103-110, 2023. e-Pub 2023. PMID: 37214207.
- Lopez-Olivo MA, Duhon GF, Ruiz JI, Altan M, Tawbi H, Diab A, Bingham CO, Calabrese C, Heredia NI, Volk RJ, Suarez-Almazor ME. Physician views on the provision of information on immune checkpoint inhibitor therapy to patients with cancer and pre-existing autoimmune disease: a qualitative study. Cancers (Basel) 15(10), 2023. e-Pub 2023. PMID: 37345026.
- Negrón JB, Lopez-Olivo MA, Carmona L, Christensen R, Ingegnoli F, Zamora NV, Gamez-Nava JI, Gonzalez-Lopez L, Strand V, Goel N, Westrich-Robertson T, Suarez-Almazor ME. Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group. Semin Arthritis Rheum 58:152028, 2023. e-Pub 2023. PMID: 35654619.
- Ghosh N, Couette N, van Binsbergen WH, Weinmann SC, Jivanelli B, Shea B, Bass AR, Benesova K, Bingham CO, Calabrese C, Cappelli LC, Chan KK, Choy E, Daoussis D, Goodman S, Hudson M, Jamal S, Leipe J, Lopez-Olivo MA, Suarez-Almazor M, van der Laken CJ, Meara AS, Liew D, Kostine M. Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: a scoping review by the OMERACT irAE working group. Semin Arthritis Rheum 58:152110, 2023. e-Pub 2023. PMID: 36372016.
- Ruiz JI, Lopez-Olivo MA, Geng Y, Suarez-Almazor ME. COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis. J Immunother Cancer 11(2), 2023. e-Pub 2023. PMID: 36746512.
- Reid, PD, Sandigursky, S, Song, J, Lopez-Olivo MA, Safa, H, Cytryn, S, Efuni, E, Buni, M, Pavlick, AC, Krogsgaard, M, Abu-Shawer, O, Altan, M, Weber, JS, Rahma, OE, Suarez-Almazor, M, Diab, A, Hassan, NA. Safety, and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. OncoImmunology 12(1), 2023. e-Pub 2023. PMID: 38126033.
- Tan NQP, Maki KG, Lopez-Olivo MA, Geng Y, Volk RJ. Cultural influences on shared decision-making among Asian Americans: A systematic review and meta-synthesis of qualitative studies. Patient Educ Couns S0738-3991(22):00823-0, 2023. e-Pub 2023. PMID: 36344320.
- Lopez-Olivo, MA, Sharma, G, Singh, G, James, J, Krause, KJ, Cinciripini, PM, Volk, R, Suarez-Almazor, M. A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis. PloS one 17(12 December), 2022. e-Pub 2022. PMID: 36520847.
- Bruera S, Ventura MJ, Agarwal SK, Krause KJ, Lopez-Olivo MA. The utility of erythrocyte sedimentation rate, C-reactive protein, and procalcitonin in detecting infections in patients with systemic lupus erythematosus: A systematic review. Lupus 31(10):9612033221106157, 2022. e-Pub 2022. PMID: 35650026.
- Nazer L, Lopez-Olivo MA, Brown AR, Cuenca J, Sirimaturos M, Khader H, Alqadheeb N, May H, Milano V, Taylor A, Nates J. A systematic review and meta-analysis evaluating geographical variation in outcomes of cancer patients treated in intensive care units. Crit Care Explor 4(9):0757, 2022. e-Pub 2022. PMID: 36119395.
- Shen C, Tannenbaum D, Horn R, Rogers J, Eng C, Johnson B, Kopetz S, Morris V, Overman M, Parseghian C, Chang G, Lopez -Olivo MA, Kanwal R, Dasari A. Shifting patterns in the design and outcomes of phase III clinical trials in advanced colorectal cancer. JAMA Netw Open 5(5):e2213588, 2022. e-Pub 2022. PMID: 35608860.
- Frade, S, Cameron, M, Espinosa-Cuervo, G, Suarez-Almazor, M, Lopez-Olivo, MA. Exercise and physical therapy for systemic sclerosis. Cochrane Database of Systematic Reviews 2022(3), 2022. e-Pub 2022.
- Yadav, D, Hwang, H, Qiao, W, Upadhyay, R, Chapin, BF, Tang, C, Aparicio, A, Lopez-Olivo, MA, Kang, SK, Macapinlac, HA, Bathala, TK, Surasi, DS. 18F-fluciclovine versus PSMA PET imaging in primary tumor detection during initial staging of high-risk prostate cancer. Radiology: Imaging Cancer 4(2), 2022. e-Pub 2022. PMID: 35212559.
- Tan NQP, Nishi SPE, Lowenstein LM, Mendoza TR, Lopez-Olivo MA, Crocker LC, Sepucha KR, Volk RJ. Impact of the shared decision-making process on lung cancer screening decisions. Cancer Med 11(3):790-797, 2022. e-Pub 2022. PMID: 34964284.
- Lopez -Olivo MA, des Bordes JKA, Jibaja-Weiss M, Volk RJ, Suarez-Almazor ME. Preferred strategies for delivering health information to patients with musculoskeletal disorders: a qualitative study. J Clin Rheumatol 28(1):e102-e109, 2022. e-Pub 2022. PMID: 33298811.
- Bruera S, Lopez-Olivo MA, Siddhanamatha HR, Molony DA, Mayes MD, Suarez-Almazor ME. Stem cell transplantation for systemic sclerosis. Cochrane Database Syst Rev 7(7):CD011819, 2022. e-Pub 2022. PMID: 35904231.
- Lowenstein LM, Nishi SPE, Lopez-Olivo MA, Crocker LC, Choi N, Kim B, Shih YT, Volk RJ. Smoking cessation services and shared decision-making practices among lung cancer screening facilities: a cross-sectional study. Cancer 128(10):1967-1975, 2022. e-Pub 2022. PMID: 35157302.
- Bommareddy K, Hamade H, Lopez-Olivo MA, Wehner M, Tosh T, Barbieri JS. Association of spironolactone use with risk of cancer: a systematic review and meta-analysis. JAMA Dermatol 158(3):275-282, 2022. e-Pub 2022. PMID: 35138351.
- Suarez-Almazor ME, Pundole X, Cabanillas G, Lei X, Zhao H, Elting LS, Lopez-Olivo MA, Giordano SH. Association of bone mineral density testing with risk of major osteoporotic fractures among older men receiving androgen deprivation therapy to treat localized or regional prostate cancer. JAMA Netw Open 5(4):e225432, 2022. e-Pub 2022. PMID: 35363269.
- Lopez-Olivo MA, Foreman JT, Leung C, Lin HY, Westrich-Robertson T, Hofstetter C, des Bordes JKA, Lyddiatt A, Leong A, Willcockson IU, Peterson SK, Suarez-Almazor ME. A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis. Semin Arthritis Rheum 56:152072, 2022. e-Pub 2022. PMID: 35872394.
- Lopez-Olivo MA, Valerio V, Karpes Matusevich AR, Brizio M, Kwok M, Geng Y, Suarez-Almazor ME, Colmegna I. Safety and efficacy of influenza vaccination in patients receiving immune checkpoint inhibitors. Systematic review with meta-analysis. Vaccines (Basel) 10(8):1195, 2022. e-Pub 2022. PMID: 36016085.
- Ruiz JI, Singh G, Erck M, Geng Y, Suarez-Almazor ME, Lopez-Olivo MA. Quality and content evaluation of websites with information about immune checkpoint inhibitors: an environmental scan. PLoS One 17(10):e0275676, 2022. e-Pub 2022. PMID: 36215234.
- Nazer L, Lopez-Olivo MA, Brown AR, Cuenca J, Sirimaturos M, Khader H, Alqadheeb N, May H, Milano V, Taylor A, Nates J. Support Care Cancer. All-cause mortality in cancer patients treated for sepsis in intensive care units: a systematic review and meta-analysis 1(11):10099-10109, 2022. e-Pub 2022. PMID: 36214879.
- Mama SK, Lopez-Olivo MA, Bhuiyan N, Leach HJ. Effectiveness of physical activity interventions among rural cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 30(12):2143-2153, 2021. e-Pub 2021. PMID: 34620628.
- Karpes Matusevich AR, Duan Z, Zhao H, Lal LS, Chan W, Suarez-Almazor ME, Giordano SH, Swint JM, Lopez -Olivo MA. Treatment sequences after discontinuing a tumor necrosis factor inhibitor in patients with rheumatoid arthritis. A comparison of cycling versus swapping strategies. Arthritis Care Res (Hoboken) 73(10):1461-1469, 2021. e-Pub 2021. PMID: 32558339.
- Lopez -Olivo MA, Lin H, Rizvi T, Barbo Barthel A, Ingleshwar A, des Bordes JKA, Jibaja-Weiss M, Volk RJ, Suarez-Almazor ME. Randomized controlled trial of patient education tools for patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 73(10):1470-1478, 2021. e-Pub 2021. PMID: 32583971.
- Bruera S, Carmona L, Lopez-Olivo MA, Westrich-Robertson T, March L, Negron JB, Christensen R, Strand V, Ingegnoli F, Goel N, Shea B, Tugwell P, Leong A, Bingham CO, Hill CL, Suarez-Almazor ME. Development of a patient-centered core domain set for prospective observational longitudinal outcome studies in rheumatoid arthritis: an OMERACT initiative. Semin Arthritis Rheum 51(5):1113-1116, 2021. e-Pub 2021. PMID: 34446270.
- Makhnoon S, Bednar EM, Krause KJ, Peterson SK, Lopez-Olivo MA. Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis. Clin Genet 100(2):119-131, 2021. e-Pub 2021. PMID: 33843052.
- Nishi SPE, Lowenstein LM, Mendoza TR, Lopez -Olivo MA, Crocker LC, Sepucha K, Niu J, Volk RJ. Shared decision-making for lung cancer screening: how well are we "sharing"?. Chest 160(1):330-340, 2021. e-Pub 2021. PMID: 33556362.
- Maki KG, Liao K, Lowenstein LM, Lopez -Olivo MA, Volk RJ. Factors associated with obtaining lung cancer screening among persons who smoke. MDM Policy Pract 6(2):23814683211067810, 2021. e-Pub 2021. PMID: 34993342.
- Lopez -Olivo MA, Zogala RJ, des Bordes J, Zamora NV, Christensen R, Rai D, Goel N, Carmona L, Pratt G, Strand V, Suarez-Almazor ME. Outcomes reported in prospective long-term observational studies and registries of patients with rheumatoid arthritis worldwide: an OMERACT systematic review. Arthritis Care Res (Hoboken) 73(5):649-657, 2021. e-Pub 2021. PMID: 32004421.
- Lopez -Olivo MA, des Bordes JK, Lin H, Volk RJ, Rizvi T, Suarez-Almazor ME. A randomized controlled trial comparing two self-administered educational strategies for patients with knee osteoarthritis. ACR Open Rheumatol 3(3):185-195, 2021. e-Pub 2021. PMID: 33590950.
- Lopez -Olivo MA, Minnix JA, Fox JG, Nishi SPE, Lowenstein LM, Maki KG, Leal VB, Tina Shih YC, Cinciripini PM, Volk RJ. Smoking cessation and shared decision-making practices about lung cancer screening among primary care providers. Cancer Med 10(4):1357-1365, 2021. e-Pub 2021. PMID: 33463091.
- Lopez-Olivo MA, des Bordes JKA, Syed MN, Alemam A, Dodeja A, Abdel-Wahab N, Suarez-Almazor ME. Quality appraisal of educational websites about osteoporosis and bone health. Arch Osteoporos 16(1):28, 2021. e-Pub 2021. PMID: 33566216.
- Karpes Matusevich AR, Lai LS, Chan W, Swint JM, Cantor SB, Suarez-Almazor ME, Lopez -Olivo MA. Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis. J Manag Care Spec Pharm 27(1):73-83, 2021. e-Pub 2021. PMID: 33377443.
- Yadav D, Hwang H, Qiao W, Wang X, Chapin B, Tang C, Aparicio A, Lopez -Olivo MA, Kang S, Macapinlac H, Tharakeswara B, Shilpa Surasi D. 18F-fluciclovine versus PSMA PET imaging in the initial staging of primary tumor in high-risk prostate cancer: a systematic review and meta-analysis. Radiology: Imaging Cancer, 2021. e-Pub 2021.
- Lopez-Olivo MA, Maki KG, Choi NJ, Hoffman RM, Shih YT, Lowenstein LM, Hicklen RS, Volk RJ. Patient adherence to screening for lung cancer in the US: a systematic review and meta-analysis. JAMA Netw Open 3(11):e2025102, 2020. e-Pub 2020. PMID: 33196807.
- Lopez -Olivo MA, Ingleshwar A, Landon GC, Siff SJ, Barbo A, Lin HY, Suarez-Almazor ME. Psychosocial determinants of total knee arthroplasty outcomes two years after surgery. ACR Open Rheumatol 2(10):573-581, 2020. e-Pub 2020. PMID: 32969193.
- Laserna A, Durán-Crane A, Lopez-Olivo MA, Cuenca JA, Fowler C, Díaz DP, Cardenas YR, Urso C, O'Connell K, Fowler C, Price KJ, Sprung CL, Nates JL. Pain management during the withholding and withdrawal of life support in critically ill patients at the end-of-life: a systematic review and meta-analysis. Intensive Care Med 46(9):1671-1682, 2020. e-Pub 2020. PMID: 32833041.
- Paramasivan A, Lopez-Olivo MA, Foong TW, Tan YW, Yap APA. Intrathecal dexmedetomidine and postoperative pain: A systematic review and meta-analysis of randomized controlled trials. Eur J Pain 24(7):1215-1227, 2020. e-Pub 2020. PMID: 32333825.
- des Bordes JKA, Foreman J, Westrich-Robertson T, Lopez -Olivo MA, Peterson SK, Hofstetter C, Lyddiatt A, Willcockson I, Leong A, Suarez-Almazor ME. Interactions, and perceptions of patients with rheumatoid arthritis participating in an online support group. Clin Rheumatol 39(6):1775-1782, 2020. e-Pub 2020. PMID: 32006180.
- Lopez -Olivo MA, des Bordes JKA, Lin H, Rizvi T, Volk RJ, Suarez-Almazor ME. Comparison of multimedia and printed patient education tools for patients with osteoporosis: a 6-month randomized controlled trial. Osteoporos Int 31(5):857-866, 2020. e-Pub 2020. PMID: 31844906.
- Abdel-Wahab N, Tayar JH, Fa'ak F, Sharma G, Lopez -Olivo MA, Yousif A, Shagroni T, Al-Hawamdeh S, Rojas-Hernandez CM, Suarez-Almazor ME. Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors. Blood Adv 4(8):1746-1755, 2020. e-Pub 2020. PMID: 32337583.
- Karpes Matusevich AR, Suarez-Almazor ME, Cantor SB, Lal LS, Swint JM, Lopez -Olivo MA. Systematic review of economic evaluations of cycling versus swapping in patients with rheumatoid arthritis after failure to tumor necrosis factor inhibitors. Arthritis Care Res (Hoboken) 72(3):343-352, 2020. e-Pub 2020. PMID: 30801951.
- Lopez-Olivo MA, Colmegna I, Karpes Matusevich AR, Qi SR, Zamora NV, Sharma R, Pratt G, Suarez-Almazor ME. Systematic review of recommendations on the use of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and cancer. Arthritis Care Res (Hoboken) 72(3):309-318, 2020. e-Pub 2020. PMID: 30821928.
- des Bordes J, Prasad S, Pratt G, Suarez-Almazor ME, Lopez-Olivo MA. Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies. PLoS One 15(1):e0227765, 2020. e-Pub 2020. PMID: 31940409.
- Durán-Crane A, Laserna A, Lopez -Olivo MA, Cuenca JA, Díaz DP, Cardenas YR, Urso C, O'Connell K, Azimpoor K, Fowler C, Price KJ, Sprung CL, Nates JL. Clinical practice guidelines and consensus statements about pain management in critically Ill end-of-life patients: a systematic review. Crit Care Med 47(11):1619-1626, 2019. e-Pub 2019. PMID: 31517694.
- Smith GL, Lopez -Olivo MA, Advani PG, Ning MS, Geng Y, Giordano SH, Volk RJ. Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J Natl Compr Canc Netw 17(10):1184-1192, 2019. e-Pub 2019. PMID: 31590147.
- Lopez -Olivo MA, Negrón JB, Zogala RJ, Carmona L, Criner K, Goel N, Gonzalez-Lopez L, Ingegnoli F, Leong A, March L, Shea B, Strand V, Tugwell P, Westrich-Robertson T, Zamora NV, Christensen R, Suarez-Almazor ME. Core outcome sets specifically for long-term observational studies: OMERACT special interest group update in rheumatoid arthritis. J Rheumatol 46(9):1164-1167, 2019. e-Pub 2019. PMID: 30824644.
- Yap A, Lopez -Olivo MA, Dubowitz J, Hiller J, Riedel B, Collaboration Group GOR. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth 66(5):546-561, 2019. e-Pub 2019. PMID: 30834506.
- Abdel-Wahab N, Rai D, Siddhanamatha H, Dodeja A, Suarez-Almazor ME, Lopez -Olivo MA. A comprehensive scoping review to identify standards for the development of health information resources on the internet. PLoS One 14(6):e0218342, 2019. e-Pub 2019. PMID: 31220126.
- Lopez-Olivo MA, Kakpovbia-Eshareturi V, des Bordes JK, Barbo A, Christensen R, Suarez-Almazor ME. Treating early undifferentiated arthritis: a systematic review and meta-analysis of direct and indirect trial evidence. Arthritis Care Res (Hoboken) 70(9):1355-1365, 2018. e-Pub 2018. PMID: 29161466.
- des Bordes JKA, Gonzalez E, Lopez -Olivo MA, Shethia M, Nayak P, Suarez-Almazor ME. Assessing information needs and use of online resources for disease self-management in patients with rheumatoid arthritis: a qualitative study. Clin Rheumatol 37(7):1791-1797, 2018. e-Pub 2018. PMID: 29500557.
- Yap A, Lopez-Olivo MA, Dubowitz J, Pratt G, Hiller J, Gottumukkala V, Sloan E, Riedel B, Schier R. Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies. Br J Anaesth 121(1):45-57, 2018. e-Pub 2018. PMID: 29935594.
- Abdel-Wahab N, Talathi S, Lopez-Olivo MA, Suarez-Almazor ME. Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. Lupus 27(4):572-583, 2018. e-Pub 2018. PMID: 28945149.
- Lopez-Olivo MA, Ingleshwar A, Volk RJ, Jibaja-Weiss M, Barbo A, Saag K, Leong A, Suarez-Almazor ME. Development and pilot testing of multimedia patient education tools for patients with knee osteoarthritis, osteoporosis, and rheumatoid arthritis. Arthritis Care Res (Hoboken) 70(2):213-220, 2018. e-Pub 2018. PMID: 28464546.
- Abdel-Wahab N, Shah M, Lopez-Olivo MA, Suarez-Almazor ME. Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: a systematic review. Ann Intern Med 168(2):121-130, 2018. e-Pub 2018. PMID: 29297009.
- Zamora NV, Christensen R, Goel N, Klokker L, Lopez -Olivo MA, Kristensen LE, Carmona L, Strand V, Curtis JR, Suarez-Almazor ME. Critical outcomes in longitudinal observational studies, and registries in patients with rheumatoid arthritis: an OMERACT special interest group report. J Rheumatol 44(12):1894-1898, 2017. e-Pub 2017. PMID: 28620065.
- He T, Lopez-Olivo MA, Hur C, Chhatwal J. Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6. Aliment Pharmacol Ther 46(8):711-721, 2017. e-Pub 2017. PMID: 28836278.
- Des Bordes JKA, Suarez-Almazor ME, Volk RJ, Lu H, Edwards B, Lopez -Olivo MA. Online educational tool to promote bone health in cancer survivors. J Health Commun 22(10):808-817, 2017. e-Pub 2017. PMID: 28922062.
- Chhatwal J, He T, Hur C, Lopez-Olivo MA. Direct-acting antiviral agents for patients with hepatitis C virus genotype 1 infection are cost-saving. Clin Gastroenterol Hepatol 15(6):827-837.e8, 2017. e-Pub 2017. PMID: 27650326.
- Siddhanamatha HR, Heung E, Lopez-Olivo MA, Abdel-Wahab N, Ojeda-Prias A, Willcockson I, Leong A, Suarez-Almazor ME. Quality assessment of websites providing educational content for patients with rheumatoid arthritis. Semin Arthritis Rheum 46(6):715-723, 2017. e-Pub 2017. PMID: 28258768.
- Pundole X, Cheema HI, Petitto GS, Lopez-Olivo MA, Suarez-Almazor ME, Lu H. Prevention and treatment of bone loss and fractures in patients undergoing a hematopoietic stem cell transplant: a systematic review and meta-analysis. Bone Marrow Transplant 52(5):663-670, 2017. e-Pub 2017. PMID: 28112742.
- Pan X, Lopez-Olivo MA, Song J, Pratt G, Suarez-Almazor ME. Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis. BMJ Open 7(3):e013242, 2017. e-Pub 2017. PMID: 28249848.
- Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Maxwell LJ, Buchbinder R, Lopez-Olivo MA, Suarez-Almazor ME, Tugwell P, Wells GA. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev 3(3):CD012591, 2017. e-Pub 2017. PMID: 28282491.
- Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus 25(14):1520-1531, 2016. e-Pub 2016. PMID: 27060064.
- Bruera S, Barbo AG, Lopez-Olivo MA. Use of medication reminders in patients with rheumatoid arthritis. Rheumatol Int 36(11):1543-1548, 2016. e-Pub 2016. PMID: 27590013.
- Volk RJ, Linder SK, Lopez-Olivo MA, Kamath GR, Reuland DS, Saraykar SS, Leal VB, Pignone MP. Patient decision aids for colorectal cancer screening: a systematic review and meta-analysis. Am J Prev Med 51(5):779-791, 2016. e-Pub 2016. PMID: 27593418.
- Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB, Lopez-Olivo MA, Barbo AG, Landon GC, Siff SJ, Lin H, Suarez-Almazor ME. Effect of body mass index and psychosocial traits on total knee replacement costs in patients with osteoarthritis. J Rheumatol 43(8):1600-6, 2016. e-Pub 2016. PMID: 27307528.
- des Bordes JK, Abdel-Wahab N, Suarez-Almazor M, Lopez-Olivo MA. Assessing information needs on bone health in cancer survivors. J Cancer Surviv 10(3):480-8, 2016. e-Pub 2016. PMID: 26499252.
- Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC. How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. Cancer Treat Rev 46:1-8, 2016. e-Pub 2016. PMID: 27046422.
- Lopez-Olivo MA, Amezaga Urruela M, McGahan L, Pollono EN, Suarez-Almazor ME. Rituximab for rheumatoid arthritis. Cochrane Database Syst Rev 1(1):CD007356, 2015. e-Pub 2015. PMID: 25603545.
- Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME. Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev 2014(6):CD000957, 2014. e-Pub 2014. PMID: 24916606.
- Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB, Lopez-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Cost-effectiveness of total knee replacement: a prospective cohort study. Arthritis Care Res (Hoboken) 66(4):592-9, 2014. e-Pub 2014. PMID: 24124052.
- de Achaval S, Kallen MA, Mayes MD, Lopez-Olivo MA, Suarez-Almazor ME. Use of the patient-generated index in systemic sclerosis to assess patient-centered outcomes. J Rheumatol 40(8):1337-43, 2013. e-Pub 2013. PMID: 23772081.
- Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA. Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev 2013(5):CD004525, 2013. e-Pub 2013. PMID: 23728649.
- Peddi P, Lopez-Olivo MA, Pratt GF, Suarez-Almazor ME. Denosumab in patients with cancer and skeletal metastases. Cancer Treat Rev 39(1):97-104, 2013. e-Pub 2013. PMID: 22898302.
- Lopez-Olivo MA, Pratt G, Palla S, Salahudeen A. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis. Am J Kidney Dis 62(3):481-92, 2013. e-Pub 2013. PMID: 23684124.
- Lopez-Olivo MA, Shah NA, Pratt G, Risser JM, Symanski E, Suarez-Almazor ME. Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis. Support Care Cancer 20(11):2985-98, 2012. e-Pub 2012. PMID: 22956190.
- Tayar JH, Lopez-Olivo MA, Suarez-Almazor ME. Febuxostat for treating chronic gout. Cochrane Database Syst Rev 11:CD008653, 2012. e-Pub 2012. PMID: 23152264.
- Lopez-Olivo MA, Tayar JH, Martinez-López JA, Pollono EN, Cueto JP, Gonzales-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA 308(9):898-908, 2012. e-Pub 2012. PMID: 22948700.
- Lopez-Olivo MA, Andrabi TR, Palla SL, Suarez-Almazor ME. Cervical spine radiographs in patients with rheumatoid arthritis undergoing anesthesia. J Clin Rheumatol 18(2):61-6, 2012. e-Pub 2012. PMID: 22334269.
- Lopez-Olivo MA, Landon GC, Siff SJ, Edelstein D, Pak C, Kallen MA, Stanley M, Zhang H, Robinson KC, Suarez-Almazor ME. Psychosocial determinants of outcomes in knee replacement. Ann Rheum Dis 70(10):1775-81, 2011. e-Pub 2011. PMID: 21791452.
- Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol 38(1):10-20, 2011. e-Pub 2011. PMID: 20952462.
- Pollono EN, Lopez-Olivo MA, Lopez JA, Suarez-Almazor ME. A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol 29(9):947-55, 2010. e-Pub 2010. PMID: 20383550.
- Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev 7(7):CD008331, 2010. e-Pub 2010. PMID: 20614469.
- Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Ghogomu ET, Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Sao Paulo Med J 128(5):309-10, 2010. e-Pub 2010. PMID: 21181074.
- Singh, JA, Christensen, R, Wells, GA, Suarez-Almazor, M, Buchbinder, R, Lopez-Olivo, MA, Ghogomu, ET, Tugwell, P. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis. CMAJ 181(11):787-796, 2009. e-Pub 2009. PMID: 19884297.
- Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev 2013(4):CD007848, 2009. e-Pub 2009. PMID: 19821440.
- Maillefert JF, Kloppenburg M, Fernandes L, Punzi L, Günther KP, Martin Mola E, Lohmander LS, Pavelka K, Lopez-Olivo MA, Dougados M, Hawker GA. Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP). Osteoarthritis Cartilage 17(10):1293-6, 2009. e-Pub 2009. PMID: 19410033.
- Aguilar-Chavez EA, Gamez-Nava JI, Lopez-Olivo MA, Galvan-Melendres S, Corona-Sanchez EG, Loaiza-Cardenas CA, Celis A, Cardona-Muñoz EG, Gonzalez-Lopez L. Circulating leptin and bone mineral density in rheumatoid arthritis. J Rheumatol 36(3):512-6, 2009. e-Pub 2009. PMID: 19208597.
- Roundtree AK, Kallen MA, Lopez-Olivo MA, Kimmel B, Skidmore B, Ortiz Z, Cox V, Suarez-Almazor ME. Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: a systematic review. J Clin Epidemiol 62(2):128-37, 2009. e-Pub 2009. PMID: 19013763.
- Corona-Sanchez EG, Gonzalez-López L, Muñoz-Valle JF, Vazquez-Del Mercado M, Lopez-Olivo MA, Aguilar-Chavez EA, Salazar-Paramo M, Loaiza-Cardenas C, Oregon-Romero E, Navarro-Hernandez RE, Gamez-Nava JI. Circulating e-selectin and tumor necrosis factor-alpha in extraarticular involvement and joint disease activity in rheumatoid arthritis. Rheumatol Int 29(3):281-6, 2009. e-Pub 2009. PMID: 18726101.
- Lopez-Olivo MA, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review. Arthritis Rheum 59(11):1625-38, 2008. e-Pub 2008. PMID: 18975351.
- Gonzalez-López L, Sanchez-Hernandez JD, Aguilar-Chavez EA, Cota-Sanchez AR, Lopez-Olivo MA, Villa-Manzano AI, Ortega-Flores R, Espinoza-Magaña GL, Rojo-Contreras W, Cardona-Muñoz EG, Gamez-Nava JI. Hyperhomocysteinemia in ankylosing spondylitis: prevalence and association with clinical variables. Rheumatol Int 28(12):1223-8, 2008. e-Pub 2008. PMID: 18719918.
- Gossec L, Jordan JM, Mazzuca SA, Lam MA, Suarez-Almazor ME, Renner JB, Lopez-Olivo MA, Hawker G, Dougados M, Maillefert JF, in OA" OTF"ARAOM. Comparative evaluation of three semi-quantitative radiographic grading techniques for knee osteoarthritis in terms of validity and reproducibility in 1759 X-rays: report of the OARSI-OMERACT task force. Osteoarthritis Cartilage 16(7):742-8, 2008. e-Pub 2008. PMID: 18417373.
- Lopez-Olivo MA, Suarez-Almazor ME. Developing guidelines in musculoskeletal disorders. Clin Exp Rheumatol 25(6 Suppl 47):28-36, 2007. e-Pub 2007. PMID: 18021504.
- Villa-Manzano AI, Gamez-Nava JI, Salazar-Paramo M, Valera-Gonzalez IC, Garcia-Gonzalez A, Garcia-Gonzalez G, Morales-Romero J, Lopez-Olivo MA, Galvan-Ramirez LM, Ruiz-Ruvalcaba R, Cardona-Muñoz EG, Gonzalez-Lopez L. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus. Rheumatol Int 26(8):712-6, 2006. e-Pub 2006. PMID: 16231121.
- Lopez-Olivo MA, Gonzalez-López L, Garcia-Gonzalez A, Villa-Manzano AI, Cota-Sanchez AR, Salazar-Paramo M, Varon-Villalpando E, Cardona-Muñoz EG, Gamez-Nava JI. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35(2):112-6, 2006. e-Pub 2006. PMID: 16641044.
- Morales-Romero J, Cázares-Méndez JM, Gámez-Nava JI, Triano-Páez M, Villa-Manzano AI, Lopez-Olivo MA, Rodríguez-Arreola BE, González-López L. Patterns of health care in an outpatient rheumatologic clinic. Reumatol Clin 1(2):87-94, 2005. e-Pub 2005. PMID: 21794243.
Invited Articles
- Corps, K, Terry, O, Lopez-Olivo, MA. Patient voices in rheumatic immune-related adverse events. Rheumatic Disease Clinics of North America 50(2):241-254, 2024. e-Pub 2024. PMID: 38670723.
- Aguilar-Company J, Lopez-Olivo MA, Ruiz-Camps I. Multidisciplinary approach to treatment with immune checkpoint inhibitors in patients with HIV, tuberculosis, or underlying autoimmune diseases. Front Med (Lausanne) 9:875910, 2022. e-Pub 2022. PMID: 35911382.
- Lopez-Olivo MA, Suarez-Almazor ME. Digital Patient Education and Decision Aids. Rheum Dis Clin North Am 45(2):245-256, 2019. e-Pub 2019. PMID: 30952396.
- Chhatwal J, He T, Lopez-Olivo MA. Systematic review of modelling approaches for the cost effectiveness of hepatitis C treatment with direct-acting antivirals. Pharmacoeconomics 34(6):551-67, 2016. e-Pub 2016. PMID: 26748919.
- Lopez-Olivo MA, Lu H, Tayar JH. Review of tofacitinib in rheumatoid arthritis. Clinical Investigation 5(1):23-38, 2015. e-Pub 2015.
- Tayar JH, Lopez-Olivo MA, Suarez-Almazor ME. Adalimumab: eight years of experience in rheumatoid arthritis. International Journal of Clinical Rheumatology 8(2):165-84, 2013. e-Pub 2013.
- Lopez-Olivo MA, Tayar JH. Safety concerns on the use of biologic drugs for the treatment of rheumatoid arthritis. CML Rhematology 31(4):101-16, 2012. e-Pub 2012.
Review Articles
- Nargund RS, Ishizawa S, Eghbalizarch M, Yeh P, Mousavi Janbeh Saray SM, Nofal S, Geng Y, Cao P, Ostrin EJ, Meza R, Tammemagi MC, Volk RJ, Lopez-Olivo MA, Toumazis I. Natural history models for lung Cancer: A scoping review. Lung Cancer 203:108495, 2025. e-Pub 2025. PMID: 40174386.
- Astorino Nicola, J, Nataliansyah, MM, Lopez-Olivo, MA, Adegboyega, A, Hirko, KA, Chichester, LR, Nock, NL, Ginex, P, Christy, SM, Levett, P. Champions to enhance implementation of clinical and community-based interventions in cancer. Implementation Science Communications 5(1), 2024. e-Pub 2024. PMID: 39439009.
Editorials
- Lopez-Olivo MA, Tayar J, Suarez-Almazor ME. The updated guidelines on the use of rituximab in rheumatoid arthritis: Existing challenges and future opportunities. Rheumatology 50(12):2153-4, 2011. PMID: 21546350.
Letters to the Editor
- Urata, Y. Systematic review of recommendations on the use of disease-modifying antirheumatic drugs in rheumatoid arthritis and cancer. Arthritis Care Res (Hoboken) 72: 1828, 2020.
- Lopez-Olivo MA, Pratt G, Suarez-Almazor ME, Colmegna I, Karpes AR, Ruyu Qi S, Zamora NV, Sharma R. Reply to comment on: Systematic review of recommendations on the use of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and cancer. Arthritis Care Res (Hoboken) 72(12): 1828-1829, 2020.
- Yap A, Lopez -Olivo MA, Dubowitz J, Hiller J, Riedel B, Collaboration Group GOR. In reply: Comment on "Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia". Can J Anaesth 67: 152-153, 2020.
- Yap A, Lopez-Olivo MA, Dubowitz J, Hiller J, Riedel B, Collaboration Group GOR. Correction to: Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth 66: 1007-1008, 2019.
- Abdel-Wahab N, Shah M, Lopez-Olivo MA, Suarez-Almazor ME. Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease. Ann Intern Med 169: 133-134, 2018.
- Pundole X, Lopez-Olivo MA, Lu H. Calcium and vitamin D supplements and fractures in community-dwelling adults. JAMA 319: 2041-2042, 2018.
- des Bordes JKA, des Bordes JKA, Abdel-Wahab N, Abdel-Wahab N, Suarez-Almazor M, Suarez-Almazor M, Lopez-Olivo MA, Lopez-Olivo MA. Assessing information needs on bone health in cancer survivors. Beyond the Abstract - UroToday E-Newsletter.
- Gonzalez-Lopez L, Lopez-Olivo MA, Gamez-Nava JI. Relationship between homocysteine and body mass index in rheumatoid arthritis. Scand J Rheumatol 36: 243-4, 2007.
Patient Reviews
CV information above last modified July 10, 2025